Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001209191-20-052153
Filing Date
2020-09-25
Accepted
2020-09-25 20:12:14
Documents
1
Period of Report
2020-09-22

Document Format Files

Seq Description Document Type Size
1 FORM 4/A SUBMISSION doc4a.html 4/A  
1 FORM 4/A SUBMISSION doc4a.xml 4/A 6165
  Complete submission text file 0001209191-20-052153.txt   7895
Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300
NEKTAR THERAPEUTICS (Issuer) CIK: 0000906709 (see all company filings)

EIN.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1020 KIFER ROAD SUNNYVALE CA 94086
Business Address 1020 KIFER ROAD SUNNYVALE CA 94086 408-523-7587
Myriam Curet (Reporting) CIK: 0001632901 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4/A | Act: 34 | File No.: 000-24006 | Film No.: 201201823